AKT as a therapeutic target for cancer

M Song, AM Bode, Z Dong, MH Lee - Cancer research, 2019 - AACR
Many cellular processes in cancer are attributed to kinase signaling networks. V-akt murine
thymoma viral oncogene homolog (AKT) plays a major role in the PI3K/AKT signaling …

[HTML][HTML] Crosstalk of inflammatory cytokines within the breast tumor microenvironment

O Habanjar, R Bingula, C Decombat… - International journal of …, 2023 - mdpi.com
Several immune and immunocompetent cells, including dendritic cells, macrophages,
adipocytes, natural killer cells, T cells, and B cells, are significantly correlated with the …

Akt signalling in health and disease

I Hers, EE Vincent, JM Tavaré - Cellular signalling, 2011 - Elsevier
Akt (also known as protein kinase B or PKB) comprises three closely related isoforms Akt1,
Akt2 and Akt3 (or PKBα/β/γ respectively). We have a very good understanding of the …

Perturbations of the AKT signaling pathway in human cancer

DA Altomare, JR Testa - Oncogene, 2005 - nature.com
Abstract AKT/PKB (protein kinase B) kinases mediate signaling pathways downstream of
activated tyrosine kinases and phosphatidylinositol 3-kinase. AKT kinases regulate diverse …

FOXO transcription factors at the interface between longevity and tumor suppression

EL Greer, A Brunet - Oncogene, 2005 - nature.com
A wide range of human diseases, including cancer, has a striking age-dependent onset.
However, the molecular mechanisms that connect aging and cancer are just beginning to be …

Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways

L Larue, A Bellacosa - Oncogene, 2005 - nature.com
Epithelial–mesenchymal transition (EMT) is an important process during development by
which epithelial cells acquire mesenchymal, fibroblast-like properties and show reduced …

Current development of mTOR inhibitors as anticancer agents

S Faivre, G Kroemer, E Raymond - Nature reviews Drug discovery, 2006 - nature.com
Mammalian target of rapamycin (mTOR) is a kinase that functions as a master switch
between catabolic and anabolic metabolism and as such is a target for the design of …

Mechanisms of disease: oncogene addiction—a rationale for molecular targeting in cancer therapy

IB Weinstein, AK Joe - Nature clinical practice Oncology, 2006 - nature.com
There has been considerable progress in the systemic treatment of cancer because of the
rapid development and clinical application of molecular targeted agents. Although patients …

Taxanes, microtubules and chemoresistant breast cancer

BT McGrogan, B Gilmartin, DN Carney… - Biochimica et Biophysica …, 2008 - Elsevier
The taxanes, paclitaxel and docetaxel are microtubule-stabilizing agents that function
primarily by interfering with spindle microtubule dynamics causing cell cycle arrest and …

Beyond chemotherapy: targeted therapies in ovarian cancer

TA Yap, CP Carden, SB Kaye - Nature Reviews Cancer, 2009 - nature.com
Ovarian cancer is the leading cause of death from gynaecological malignancies in the
Western world. Despite the evolution of surgical techniques and meticulously designed …